APP and Alzheimer disease: In AD, brain levels of free heme and hemin are significantly elevated [399], and probably contribute to neurodegeneration by inhibiting cholinergic function, altering AβPP-Aβ metabolism, binding to hyper-phosphorylated tau and promoting tau aggregation into paired-helical filaments, and inducing formation of free radicals [399].